Sharing an Update From Polaris – ADI-PEG 20 in Glioblastoma: Preclinical Studies & Phase I-II Results
Time: 11:00 am
day: Conference Day 1
Details:
- Review preclinical studies and phase I results
- Gain an update on phase II and phase II/III studies
- Discuss the initiation of ADI-PEG 20 into GBM agile
